Variable renal atrial natriuretic factor gene expression in hypertension.

Area of Science:

• Nephrology
• Cardiovascular Physiology
• Molecular Biology

Background:

• Atrial natriuretic factor (ANF) gene expression exists in the kidney, but its role and regulation are unclear.
• Investigating the link between renal ANF expression and the renin-angiotensin system (RAS) is crucial for understanding kidney function.

Purpose of the Study:

• To determine if renal ANF gene expression is regulated by the local renin-angiotensin system (RAS).
• To compare renal ANF expression in hypertension models with activated versus depressed RAS.

Main Methods:

• Quantitative competitive reverse transcription polymerase chain reaction (RT-PCR) was used to measure renal ANF mRNA levels.
• Two rat models of hypertension were studied: suprarenal aortic banding (activated RAS) and deoxycorticosterone acetate (DOCA)-salt (depressed RAS).

Main Results:

• DOCA-salt hypertension significantly decreased renal ANF expression, while aortic banding significantly increased it.
• Cardiac ANF gene expression increased in both hypertension models.
• Ramipril treatment normalized renal ANF mRNA in aortic-banded rats, indicating local RAS modulation.

Conclusions:

• Renal ANF gene expression is modulated by the local RAS, independent of circulating RAS or hypertension itself.
• Downregulation of renal ANF in DOCA-salt hypertension may impair sodium excretion.
• Upregulation of renal ANF in aortic banding may serve a compensatory role in managing sodium retention.